CN Stock MarketDetailed Quotes

603707 Nanjing King-Friend Biochemical Pharmaceutical

Watchlist
  • 12.26
  • -0.71-5.47%
Market Closed Jan 3 15:00 CST
19.81BMarket Cap-46.79P/E (TTM)

Nanjing King-Friend Biochemical Pharmaceutical Key Stats

Nanjing King-Friend Biochemical Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.636B--
--2024/FY-- / 4.303B--
--2023/FY3.931B / 4.223B--
--2022/FY3.713B / 3.879B--
--2021/FY3.687B / 3.902B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.636B--
--2024/FY-- / 4.303B--
--2023/FY3.931B / 4.223B--
--2022/FY3.713B / 3.879B--
--2021/FY3.687B / 3.902B--

Unlock Free Earnings Estimates

Nanjing King-Friend Biochemical Pharmaceutical Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jan 5, 2025

Strong Buy

  • Strong Buy

    64.29%
  • Buy

    35.71%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data